Skip to content

Longitudinal Study of the Psychological Impact of Bariatric Surgery

Psychological Impact of Bariatric Surgery in Patients With Morbid Obesity: a Longitudinal Study Protocol

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07780058
Acronym
BARI-SCL
Enrollment
70
Registered
2026-08-21
Start date
2025-09-02
Completion date
2028-10-28
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

psychological well-being, bariatric surgery, hair cortisol, morbid obesity, follow-up

Brief summary

This prospective observational study evaluates the effect of bariatric surgery on mental health and hair cortisol in patients with morbid obesity over a 3-year follow-up. Assessments will be performed before surgery and at 1 month, 1 year, 2 years, and 3 years to analyze psychological changes, weight changes, and the need for psychological support.

Detailed description

Objective: To evaluate the impact of bariatric surgery on mental health and hair cortisol concentrations in patients with morbid obesity over a 3-year follow-up. Methods: This is a prospective observational study in candidates for bariatric surgery. Assessments will include sociodemographic data, anthropometric measures, clinical, nutritional and lifestyle variables, hair cortisol concentrations, and psychological variables, including psychopathological symptoms, stress levels, impulsivity, emotional eating, and health-related quality of life. Evaluations will be performed at five time points: preoperative (T0), 1 month (T1), 1 year (T2), 2 years (T3), and 3 years (T4). The study will describe psychological and weight changes after surgery and identify possible needs for psychological support before surgery and during mid- and long-term follow-up.

Interventions

None listed

Sponsors

University of Alicante
Lead SponsorOTHER
Instituto de Investigación Sanitaria y Biomédica de Alicante
CollaboratorNETWORK
FISABIO (Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community)
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Men and women aged 18 to 70 years who are candidates for gastric bypass, sleeve gastrectomy, or single-anastomosis duodeno-ileal bypass (SADI-S), with a body mass index of at least 40 kg/m² or at least 35 kg/m² with comorbidities, and who are able to provide informed consent.

Exclusion criteria

* Patients with previous bariatric surgery and pregnant women during follow-up will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Global Severity Index (GSI) score of the Symptom Checklist-90-Revised (SCL-90-R)Baseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in overall psychological distress assessed using the Global Severity Index (GSI) of the Symptom Checklist-90-Revised (SCL-90-R).

Secondary

MeasureTime frameDescription
Perceived Stress Scale (PSS-14) scoreBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in perceived stress assessed using the 14-item Perceived Stress Scale (PSS-14). Outcome measure: total PSS-14 score.
UPPS-P Short Version scoreBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in impulsivity assessed using the 20-item UPPS-P Short Version questionnaire. Outcome measure: total UPPS-P score and subscale scores.
Hair cortisol concentrationBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in hair cortisol concentration measured in hair samples, expressed as pg/mg of hair.
Moorehead-Ardelt Quality of Life Questionnaire II scoreBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in health-related quality of life assessed using the Moorehead-Ardelt Quality of Life Questionnaire II. Outcome measure: total questionnaire score.
Eating Disorder Examination Questionnaire (EDE-Q) scoreBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in eating disorder symptoms assessed using the Eating Disorder Examination Questionnaire (EDE-Q). Outcome measure: total EDE-Q score.
Emotional Eating Questionnaire (EEQ) scoreBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in emotional eating assessed using the Emotional Eating Questionnaire (EEQ). Outcome measure: total EEQ score.
Body weightBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgeryChange in body weight measured in kilograms (kg).
Body Mass Index (BMI)Baseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in body mass index calculated as weight divided by height squared, expressed in kg/m².
Mediterranean Diet Adherence Screener (MEDAS) scoreBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in adherence to the Mediterranean diet assessed using the 14-item Mediterranean Diet Adherence Screener (MEDAS). Outcome measure: total MEDAS score (0-14).
Sleep qualityBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in self-reported sleep quality assessed using the study-specific questionnaire. Outcome measure: sleep quality score.
Physical activityBaseline (3 months before surgery), 1 month, 1 year, 2 years, and 3 years after bariatric surgery.Change in self-reported physical activity assessed using the study-specific questionnaire.

Countries

Spain

Contacts

CONTACTLorena Andreu Lucena, MSc
lorenapsicologiabariatrica@gmail.com+34667508676
CONTACTAna M Santos, PhD
anasantos@gcloud.ua.es+34 965 90 3960
STUDY_DIRECTORCristian Marco, MD, PhD

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

STUDY_CHAIRRahma Amrani, MSc

Instituto de Investigación Sanitaria y Biomédica de Alicante

STUDY_CHAIRNieves Pérez, MD

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

STUDY_CHAIRTrinidad M Castillo, MSc

Instituto de Investigación Sanitaria y Biomédica de Alicante

STUDY_CHAIRÁngel L Abad, MD

Instituto de Investigación Sanitaria y Biomédica de Alicante

STUDY_CHAIRMyriam Sánchez, MD

Instituto de Investigación Sanitaria y Biomédica de Alicante

STUDY_CHAIRDolores M Fernández, PhD

Instituto de Investigación Sanitaria y Biomédica de Alicante

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026